Neumora Therapeutics, Inc. (NMRA) reported Loss for fourth quarter that decreased from the same period last year and beat the Street estimates.
The company's bottom line came in at -$58.82 million, or -$0.37 per share. This compares with -$108.73 million, or -$0.71 per share, last year.
Analysts on average had expected the company to earn -$0.44 per share. Analysts' estimates typically exclude special items.
Neumora Therapeutics, Inc. earnings at a glance (GAAP) :
-Earnings: -$58.82 Mln. vs. -$108.73 Mln. last year.
-EPS: -$0.37 vs. -$0.71 last year.
For comments and feedback: editorial@rttnews.com